Maplelane Capital, LLC Amgen Inc Put Options Transaction History

Maplelane Capital, LLC

  • $1.64 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$166.7 - $195.41 $31.5 Million - $36.9 Million
-189,000 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$180.87 - $203.88 $19.2 Million - $21.6 Million
-106,000 Reduced 35.93%
189,000 $35.9 Million
Q4 2018

Feb 14, 2019
BUY
$178.4 - $208.25 $52.6 Million - $61.4 Million
295,000 New
295,000 $57.4 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Maplelane Capital, LLC Portfolio

Follow Maplelane Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maplelane Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Maplelane Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email